SNY – Sanofi

SNY — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.45

Margin Of Safety %

Put/Call OI Ratio

0.76

EPS Next Q Diff

-0.09

EPS Last/This Y

1.34

EPS This/Next Y

0.35

Price

41.59

Target Price

49.8

Analyst Recom

2.1

Performance Q

-5.45

Upside

-39.4%

Beta

0.29

Ticker: SNY

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-09-28	SNY	41.18	0.80	0.09	85917
2026-09-29	SNY	40.74	0.78	0.46	86899
2026-09-30	SNY	41.23	0.78	0.23	87380
2026-10-01	SNY	40.65	0.78	0.53	87815
2026-10-02	SNY	39.92	0.77	1.15	88697
2026-10-05	SNY	39.52	0.78	0.66	90332
2026-10-06	SNY	39.56	0.77	0.46	91513
2026-10-07	SNY	40.21	0.75	1.08	93141
2026-10-08	SNY	40.22	0.76	1.10	93444
2026-10-09	SNY	40.08	0.75	0.78	93685
2026-10-12	SNY	39.75	0.75	1.34	93899
2026-10-13	SNY	39.1	0.74	1.65	93979
2026-10-14	SNY	39.76	0.73	0.31	93976
2026-10-15	SNY	40.29	0.73	4.81	94057
2026-10-16	SNY	40.59	0.75	0.20	95155
2026-10-19	SNY	39.57	0.79	0.19	90530
2026-10-20	SNY	41.4	0.78	0.57	92592
2026-10-21	SNY	40.97	0.78	2.28	93108
2026-10-22	SNY	41.95	0.78	0.24	93302
2026-10-23	SNY	41.58	0.76	0.26	94600
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-09-28	SNY	41.18	-8.0	554.2	5.02
2026-09-29	SNY	40.76	-8.0	501.2	5.02
2026-09-30	SNY	41.23	-8.0	639.6	5.02
2026-10-01	SNY	40.65	-8.0	497.3	5.02
2026-10-02	SNY	39.92	-8.0	503.8	5.02
2026-10-05	SNY	39.52	-8.0	386.6	5.02
2026-10-06	SNY	39.58	-8.0	580.5	5.02
2026-10-07	SNY	40.21	-8.0	667.2	5.02
2026-10-08	SNY	40.23	-8.0	558.3	5.02
2026-10-09	SNY	40.07	-8.0	537.2	5.02
2026-10-12	SNY	39.74	-10.7	488.5	4.93
2026-10-13	SNY	39.08	-8.1	459.7	4.95
2026-10-14	SNY	39.76	-10.7	638.2	4.93
2026-10-15	SNY	40.28	-10.7	560.7	4.93
2026-10-16	SNY	40.61	-10.7	570.6	4.93
2026-10-19	SNY	39.55	-10.7	351.6	4.93
2026-10-20	SNY	39.55	-10.7	351.6	4.93
2026-10-21	SNY	41.40	-10.7	813.9	4.93
2026-10-22	SNY	41.96	-10.7	672.8	4.93
2026-10-23	SNY	41.59	-10.7	471.4	4.93
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-09-28	SNY	0	-0.09	0.39
2026-09-29	SNY	0	-0.09	0.39
2026-09-30	SNY	0	-0.09	0.39
2026-10-01	SNY	0	-0.09	0.39
2026-10-02	SNY	0	-0.09	0.39
2026-10-05	SNY	0	-0.48	0.39
2026-10-06	SNY	0	-0.48	0.39
2026-10-07	SNY	0	-0.48	0.39
2026-10-08	SNY	0	-0.48	0.39
2026-10-09	SNY	0	-0.48	0.39
2026-10-12	SNY	0	-0.37	0.45
2026-10-13	SNY	0	-0.37	0.45
2026-10-14	SNY	0	-0.37	0.45
2026-10-15	SNY	0	-0.37	0.45
2026-10-16	SNY	0	-0.37	0.45
2026-10-19	SNY	0	-0.55	0.45
2026-10-20	SNY	0	-0.55	0.45
2026-10-21	SNY	0	-0.55	0.45
2026-10-22	SNY	0	-0.55	0.45
2026-10-23	SNY	0	-0.55	0.45
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.21

Avg. EPS Est. Current Quarter

1.51

Avg. EPS Est. Next Quarter

1.12

Insider Transactions

Institutional Transactions

-0.55

Beta

0.29

Average Sales Estimate Current Quarter

13186

Average Sales Estimate Next Quarter

12787

Fair Value

51.63

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

30.8

Max Drawdown 5-Year %

-33.5

Target Price

49.8

P/E

21.43

Forward P/E

8.08

PEG

1.36

P/S

1.85

P/B

1.28

P/Free Cash Flow

8.23

EPS

1.94

Average EPS Est. Cur. Y

4.93

EPS Next Y. (Est.)

5.28

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.78

Relative Volume

0.67

Return on Equity vs Sector %

-19.9

Return on Equity vs Industry %

-29.4

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.08

EBIT Estimation

471.4

◆ SNY Healthcare

$41.60

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

13/25

Volume

6/15

Valuation

16/20

TP/AR

1/10

Options

3/10

RSI

53.4

Range 1M

79.8%

Sup Dist

0.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

9/30

Estimates

5/20

Inst/Vol

0/15

Options

7/10

EPS Yr

3.5%

EPS NY

6.6%

52W%

17.8%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +43.7% upside

Quality

10/30

Valuation

20/30

Growth

8/25

Stability

3/10

LT Trend

1/5

Upside

+43.7%

Quality

MoS

24%

SNY — P/E HistoricalDrug Manufacturers - General

Sanofi

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 74846

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu vaccine. It has a collaboration and license agreement with Exscientia to develop small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab; and antibody collaboration with Regeneron Pharmaceuticals, Inc. to develop antibodies, such as Dupixent (dupilumab) as treatment for diseases driven by type 2 inflammation. manufacturing facility in Germany. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

SNY

Latest News

—

Caricamento notizie per SNY…

stock quote shares SNY – Sanofi Stock Price stock today

news today SNY – Sanofi stock forecast ,stock prediction 2023 2024 2025

marketwatch SNY – Sanofi yahoo finance google finance

stock history SNY – Sanofi invest stock market

stock prices SNY premarket after hours

ticker SNY fair value insiders trading

SNY – Sanofi

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SNY

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y